This inventor holds 1 USPTO granted patent. Top assignee: Rohto Pharmaceutical Co., Ltd.. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: Kenji Muta: Innovator in Pharmaceutical Formulations
Introduction
Kenji Muta is a notable inventor based in Shiga, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations. His work has led to advancements that enhance the stability and effectiveness of pharmaceutical products.
Latest Patents
Kenji Muta holds a patent for a pharmaceutical formulation in the form of an aqueous suspension. This formulation comprises an ion exchange resin carrying an active ingredient and a suspending agent. It is characterized by the inclusion of a basic or neutral amino acid or a salt thereof, which serves as a dispersion stabilizer. This innovation is crucial for improving the delivery and efficacy of medications.
Career Highlights
Muta is associated with Rohto Pharmaceutical Co., Ltd., a company known for its commitment to research and development in the pharmaceutical industry. His work at Rohto has allowed him to focus on creating formulations that meet the evolving needs of patients and healthcare providers.
Collaborations
Throughout his career, Kenji Muta has collaborated with talented individuals such as Youko Mitani and Mitsuo Umemoto. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Kenji Muta's contributions to pharmaceutical formulations exemplify the impact of innovative thinking in the healthcare sector. His patent and collaborative efforts highlight the importance of research and development in creating effective medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
